Oliva Robert Letterio 4
4 · Novo Integrated Sciences, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Oliva Robert Letterio
Director
Transactions
- Award
Stock Option (right to buy)
2022-02-23+93,995→ 93,995 totalExercise: $1.33From: 2022-02-23Exp: 2027-02-23→ Common Stock (93,995 underlying)
Holdings
- 207,717
Common Stock
Footnotes (1)
- [F1]Represents a grant approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 7,833 shares each month, beginning on the date of grant, until December 23, 2022 and with respect to 7,832 shares on January 23, 2023.